Provenance du réseau au premier degré de Johannes Nippgen
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Johannes Nippgen via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
| Nanjing University | College/University | Undergraduate Degree Undergraduate Degree | |
Matthews International Capital Management LLC
 Matthews International Capital Management LLC Investment ManagersFinance Matthews International Capital Management LLC (dba Matthews Asia) is an independent, SEC-registered investment advisor and mutual fund manager headquartered in San Francisco, California. The firm was founded by Paul Matthews in 1991. Matthews Asia manages portfolios for institutional clients, pension and profit-sharing plans, insurance companies, endowments and foundations and other business entities around the world. | Investment Managers | Corporate Officer/Principal | |
| University of Padua | College/University | Doctorate Degree | |
| Shanghai Jiao Tong University School of Medicine | College/University | Undergraduate Degree | |
| China Europe International Business School | College/University | Masters Business Admin | |
Genor Biopharma Co., Ltd.
 Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Biotechnology | Corporate Officer/Principal | |
| China Agricultural University | College/University | Graduate Degree | |
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
 Jiangsu Alphamab Biopharmaceuticals Co., Ltd Pharmaceuticals: MajorHealth Technology Part of Suzhou Alphamab Co., Ltd., Jiangsu Alphamab Biopharmaceuticals Co., Ltd is a company that manufactures and distributes therapeutics for cancer treatment. Jiangsu Alphamab Biopharmaceuticals Co., Ltd is based in Suzhou, China. The Chinese company was founded in 2015 by Ting Xu. Ting Xu has been the CEO since 2015. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Shanghai Institute of Materia Medica Chinese Academy of Sci | College/University | Doctorate Degree | |
| MICROPORT CARDIOFLOW MEDTECH CORPORATION | Medical Specialties | Director/Board Member | |
The Permal Group Ltd.
 The Permal Group Ltd. Investment Trusts/Mutual FundsMiscellaneous The Permal Group Ltd. provides asset management services. It offers multi-manager and single manager funds, separate accounts and structured products. The company is headquartered in New York, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| East China Normal University | College/University | Graduate Degree | |
| HBM HOLDINGS LIMITED | Pharmaceuticals: Other | Director of Finance/CFO | |
| Columbia Business School | College/University | Graduate Degree | |
| Stony Brook University | College/University | Undergraduate Degree | |
Lansdowne Partners (UK) LLP
 Lansdowne Partners (UK) LLP Investment ManagersFinance Lansdowne Partners (UK) LLP (Lansdowne) is the alternative investment management subsidiary of Lansdowne Partners Ltd., itself a subsidiary of Lansdowne Partners International Ltd. in the Cayman Islands. The firm is headquartered in London and was founded in 1998. Lansdowne provides investment advisory services on a discretionary basis to their clients, which includes commingled investment vehicles intended for institutional investors and other sophisticated investors and investment vehicles formed for particular investors and separately managed accounts for sophisticated financial institutions, including registered investment companies. Lansdowne is a signatory to the United Nations Principles of Responsible Investing (UNPRI). | Investment Managers | Corporate Officer/Principal | |
| JIANGSU AIDEA PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Chine | 13 |
| Etats-Unis | 6 |
| Italie | 2 |
| Royaume-Uni | 2 |
Sectorielle
| Consumer Services | 10 |
| Health Technology | 8 |
| Finance | 3 |
| Miscellaneous | 2 |
Opérationnelle
| Director/Board Member | 6 |
| Corporate Officer/Principal | 6 |
| Independent Dir/Board Member | 5 |
| Undergraduate Degree | 4 |
| Graduate Degree | 3 |
Relations les plus connectées
| Insiders | |
|---|---|
| Weihao Xu | 8 |
| Hua Liang Jiang | 6 |
| Jing Han | 5 |
| Yumin Wan | 4 |
| Zijian Guo | 3 |
- Bourse
- Insiders
- Johannes Nippgen
- Connexions Sociétés
